The use of botulinum toxin injections in the management of acquired nystagmus and oscillopsia

Clinical Rehabilitation

Volumn 10, Issue 3, 1996, Pages 205-209

  Kosmin, A S ^a   Marsh, I B ^a   Batterbury, M ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; SPASMOLYTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DIPLOPIA; DRUG EFFICACY; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; MALE; NYSTAGMUS; PTOSIS; VESTIBULOOCULAR REFLEX; VISUAL ACUITY; WHEELCHAIR;

EID: 0029901183     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921559601000304     Document Type: Article

References (20)

1. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 1973; 12: 924-27.
2. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981; 79: 734-70.
3. Osako M, Kellner JL. Botulinum toxin A in ophthalmology. Surv Ophthalmol 1991; 36: 28-46.
4. Dunlop D, Pittar G, Dunlop C. Botulinum toxin in ophthalmology. Aust N Z J Ophthalmol 1988; 16: 15-20.
5. Williams A. Consensus statement for the management of focal dystonias. Br J Hosp Med 1993; 50: 655-59.
6. Denislic M, Pirtosek Z, Vodusek DB, Zidar J, Meh D. Botulinum toxin in the treatment of neurological disorders. Ann N Y Acad Sci 1994; 710: 76-87.
7. Stanley EF, Drachman DB. Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction. Brain Res 1983; 261: 172-75.
8. Duchen LW. An electron microscopic study of the changes induced by botulinum toxin in the motor end plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 1971; 14: 47-60.
9. Helveston EM, Pogrebniak AE. Treatment of acquired nystagmus with botulinum A toxin. Am J Ophthalmol 1988; 106: 584-86.
10. Ruben ST, Lee JP, O'Neil D, Dunlop I, Elston J. The use of botulinum toxin for the treatment of acquired nystagmus and oscillopsia. Ophthalmology 1994; 101: 783-87.
11. Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol 1994; 112: 1320-24.
12. Crone RA, de Jong PJVM, Notermans G. Behaudlung des Nystagmus durch Injection von Klin. Monatsbl Augenheikd 1984; 184: 216-17.
13. Leigh RJ, Tomsak RL, Grant MP, Remler FB, Yaniglos SS, Lystad L, Dell'Osso LF. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 1992; 32: 633-42.
14. Carlow TJ. Medical treatment of nystagmus and ocular motor disorders. Int Ophthalmol Clin 1986; 26: 251-64.
15. Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double blind, randomised trial of three intravenous drugs. Ann Neurol 1994; 35: 319-25.
16. Leigh RJ, Averbuch-Heller L, Tomsak RL, Remler BF, Yaniglos SS, Dell'Osso LF. Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol 1994; 36: 129-41.
17. Leigh RJ, Rushton DN, Thurston SE, Hertle RW, Yaniglos SS. Effects of retinal image stabilisation in acquired nystagmus due to neurologic disease. Neurology 1988; 38: 122-27.
18. Lee JP. Surgical management of nystagmus. Eye 1988; 2: 44-47.
19. Tomsak RL, Remler BF, Averbuch-Heller L, Chandran M, Leigh RJ. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol 1994; 119: 489-96.
20. Hart WM Jr ed. Adlers physiology of the eye, ninth edition. St Louis, MO: Mosby Year Book, Inc., 1992: 5, 163-67.